Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical Trial Liability: Attorneys And Consultants Offer Tips On Reducing Risk

Executive Summary

As the number of clinical trials proliferate, so too do the situations that can lead to litigation

You may also be interested in...

IoM Report On Postmarketing Study Ethics Could Drive Broad Overhaul Of Informed Consent

Released in advance of Avandia advisory committee meeting, Institute of Medicine report provides a "conceptual framework" for deciding whether safety studies such as TIDE are ethical.

Foreign Trials, U.S. Liability: Pfizer Dealt Setback As Solicitor General Asks Supreme Court Not To Review Nigerians' Trovan Suit

If the Supreme Court lets appeals court decision stand, pharmaceutical firms could find themselves facing more litigation regarding clinical trials conducted overseas.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts